Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
10.08
-0.57 (-5.35%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Beta Bionics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | 110.24 | 100.25 | 65.12 | 12 | 0.18 |
| Revenue Growth (YoY) | 57.87% | 53.94% | 442.93% | 6601.12% | - |
| Cost of Revenue | 47.24 | 44.71 | 29.24 | 5.69 | - |
| Gross Profit | 63 | 55.54 | 35.89 | 6.31 | 0.18 |
| Selling, General & Admin | 102.76 | 92.43 | 54.96 | 24.22 | 33.5 |
| Research & Development | 37.56 | 34.79 | 26.18 | 17.94 | 31.43 |
| Operating Expenses | 140.31 | 127.22 | 81.14 | 42.16 | 64.92 |
| Operating Income | -77.31 | -71.68 | -45.25 | -35.85 | -64.74 |
| Interest Expense | - | - | - | - | -0.01 |
| Interest & Investment Income | 10.87 | 10.93 | 3.91 | 1.78 | 0.2 |
| Other Non Operating Income (Expenses) | -0 | -12.45 | -13.41 | -10.03 | 0.91 |
| EBT Excluding Unusual Items | -66.44 | -73.2 | -54.76 | -44.1 | -63.65 |
| Other Unusual Items | - | - | - | - | -1.1 |
| Pretax Income | -66.44 | -73.2 | -54.76 | -44.1 | -64.75 |
| Net Income | -66.44 | -73.2 | -54.76 | -44.1 | -64.75 |
| Net Income to Common | -66.44 | -73.2 | -54.76 | -44.1 | -64.75 |
| Shares Outstanding (Basic) | 44 | 41 | 6 | 5 | 5 |
| Shares Outstanding (Diluted) | 44 | 41 | 6 | 5 | 5 |
| Shares Change (YoY) | 250.60% | 536.74% | 20.01% | 6.13% | - |
| EPS (Basic) | -1.51 | -1.81 | -8.60 | -8.31 | -12.96 |
| EPS (Diluted) | -1.51 | -1.81 | -8.60 | -8.31 | -12.96 |
| Free Cash Flow | -61.12 | -56.22 | -51.67 | -32.85 | -60.98 |
| Free Cash Flow Per Share | -1.39 | -1.39 | -8.12 | -6.19 | -12.20 |
| Gross Margin | 57.15% | 55.40% | 55.11% | 52.59% | 100.00% |
| Operating Margin | -70.13% | -71.50% | -69.48% | -298.88% | -36169.83% |
| Profit Margin | -60.27% | -73.02% | -84.08% | -367.64% | -36173.74% |
| Free Cash Flow Margin | -55.45% | -56.08% | -79.34% | -273.84% | -34067.04% |
| EBITDA | -75.46 | -70.11 | -44.1 | -34.62 | -63.4 |
| EBITDA Margin | -68.45% | -69.93% | -67.72% | -288.65% | - |
| D&A For EBITDA | 1.86 | 1.57 | 1.15 | 1.23 | 1.35 |
| EBIT | -77.31 | -71.68 | -45.25 | -35.85 | -64.74 |
| EBIT Margin | -70.13% | -71.50% | -69.48% | -298.87% | - |
| Revenue as Reported | - | - | - | - | 0.18 |
Source: S&P Capital IQ. Standard template.
Financial Sources.